Why Citigroup Inc (C) Got Hammered This Week

About three hours into the week’s final day of trading, Citigroup Inc (NYSE:C) stock is down a staggering 6.80%. There’s no mystery as to what’s behind the plummet, as well as the rest of the market’s demise this week: a little thing Ben Bernanke likes to call “tapering.”

Citigroup Inc (NYSE:C)

The Fed giveth, and the Fed taketh away
In case you missed it, here’s the overview: On Wednesday, the Federal Reserve chairman announced his plan to taper quantitative easing, the bond-buying program investors have come to mentally rely on as they’ve piled more and more money into the stock market.

So long as the economy continues to improve, the pace of bond-purchases will begin to slow later this year, with a target of mid-2014 for a complete halt to buying. By then, the rate of unemployment is projected to be down to 7%. Finally, interest rates will be kept low until unemployment drops to 6.5%.

Foolish bottom line
With this announcement, markets of all kinds all over the world have been freaking out: Equity markets have tumbled, bond yields are rising, and commodity prices are dropping. Here at home, the S&P 500 is down 3.24% for the week, the Dow Jones Industrial Average is down 2.98%, and the Nasdaq is down 3.29%.

Of course, no one should be surprised at the Fed’s move. Bernanke’s been talking about tapering for months, without announcing any firm plans. I think it’s obvious he’s been trying to prepare investors for the inevitable: that QE had to end sometime, and that time is now. Although that isn’t even the case: Tapering will only begin later this year, and then only if the economic data remains positive.

Still, the markets will do what they will do, and there’s an argument to be made that a stock market bubble had formed because of the excess liquidity the Fed has been pumping into the system for years now, but especially since last September, when the third round of QE began. So as long as this market tumble stabilizes soon, investors will have cause to be joyful: bubbles aren’t good for anyone, because once they pop, what should have been a reasonable correction can turn into panic and subsequent rout.

Citigroup Inc (NYSE:C) really took it on the chin this week, though. It’s performance was worse than even that of Bank of America Corp (NYSE:BAC)‘s. It’s possible investors are concerned about breaking news out of the U.K., involving a Citigroup Inc (NYSE:C) trader being criminally charged with manipulating the LIBOR. So far, the scandal seems contained, but it’s early on, and investors may be lumping that and the Fed’s announcement together.

But as always, Fools, stay focused on the fundamentals of the companies you’re invested in, and tune out the market noise. Obsessive ticker checking can lead to more trades, which costs money, and can also lead to poorer portfolio performance. I personally own stock in Citigroup Inc (NYSE:C), and would counsel other investors to hold their positions through this bit of market turbulence. This drop could even be looked at as a buying opportunity.

The article Why Citigroup Got Hammered This Week originally appeared on Fool.com.

Fool contributor John Grgurich owns shares of Citigroup, Follow John’s dispatches from the not-so-muddy trenches of high-finance and big-banking on Twitter @TMFGrgurichThe Motley Fool recommends Bank of America. The Motley Fool owns shares of Bank of America and Citigroup.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!